Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of 4mg Nicotine Lozenges
NCT01669122Phase 2Completed
- Sponsor
- GSK
- Start
- Jun 2012
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nicotine in nicotine dependence, sponsored by GSK. Started Jun 2012; status: completed.
02
Drugs
nicotine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01669122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01669122.